Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

PURPOSE: To investigate the expression pattern of hypoxia-induced proteins identified as being involved in malignant progression of head-and-neck squamous cell carcinoma (HNSCC) and to determine their relationship to tumor pO(2) and prognosis. METHODS AND MATERIALS: We performed immunohistochemical staining of hypoxia-induced proteins (carbonic anhydrase IX [CA IX], BNIP3L, connective tissue growth factor, osteopontin, ephrin A1, hypoxia inducible gene-2, dihydrofolate reductase, galectin-1, IkappaB kinase beta, and lysyl oxidase) on tumor tissue arrays of 101 HNSCC patients with pretreatment pO(2) measurements. Analysis of variance and Fisher's exact tests were used to evaluate the relationship between marker expression, tumor pO(2), and CA IX staining. Cox proportional hazard model and log-rank tests were used to determine the relationship between markers and prognosis. RESULTS: Osteopontin expression correlated with tumor pO(2) (Eppendorf measurements) (p = 0.04). However, there was a strong correlation between lysyl oxidase, ephrin A1, and galectin-1 and CA IX staining. These markers also predicted for cancer-specific survival and overall survival on univariate analysis. A hypoxia score of 0-5 was assigned to each patient, on the basis of the presence of strong staining for these markers, whereby a higher score signifies increased marker expression. On multivariate analysis, increasing hypoxia score was an independent prognostic factor for cancer-specific survival (p = 0.015) and was borderline significant for overall survival (p = 0.057) when adjusted for other independent predictors of outcomes (hemoglobin and age). CONCLUSIONS: We identified a panel of hypoxia-related tissue markers that correlates with treatment outcomes in HNSCC. Validation of these markers will be needed to determine their utility in identifying patients for hypoxia-targeted therapy.

Original publication

DOI

10.1016/j.ijrobp.2007.01.071

Type

Journal article

Journal

Int J Radiat Oncol Biol Phys

Publication Date

01/09/2007

Volume

69

Pages

167 - 175

Keywords

Analysis of Variance, Antigens, Neoplasm, Biomarkers, Tumor, Carbonic Anhydrase IX, Carbonic Anhydrases, Carcinoma, Squamous Cell, Cell Hypoxia, Cell Line, Tumor, Disease Progression, Ephrin-A1, Female, Galectin 1, Head and Neck Neoplasms, Humans, I-kappa B Kinase, Male, Membrane Proteins, Middle Aged, Neoplasm Proteins, Osteopontin, Oxygen, Partial Pressure, Prognosis, Protein-Lysine 6-Oxidase, Proto-Oncogene Proteins, Tetrahydrofolate Dehydrogenase, Tumor Suppressor Proteins